Financial Health Report: Mirum Pharmaceuticals Inc (MIRM)’s Ratios Tell a Tale

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Mirum Pharmaceuticals Inc (NASDAQ: MIRM) closed the day trading at $38.98 up 0.13% from the previous closing price of $38.93. In other words, the price has increased by $0.13 from its previous closing price. On the day, 0.61 million shares were traded. MIRM stock price reached its highest trading level at $39.65 during the session, while it also had its lowest trading level at $38.57.

Ratios:

For a better understanding of MIRM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.09 and its Current Ratio is at 3.28. In the meantime, Its Debt-to-Equity ratio is 1.38 whereas as Long-Term Debt/Eq ratio is at 1.38.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on April 17, 2024, initiated with a Buy rating and assigned the stock a target price of $48.

On December 18, 2023, H.C. Wainwright reiterated its Buy rating and also upped its target price recommendation from $60 to $58.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 18 ’24 when Heron Patrick J bought 115 shares for $37.40 per share. The transaction valued at 4,301 led to the insider holds 162,308 shares of the business.

Heron Patrick J bought 230 shares of MIRM for $9,563 on Sep 06 ’24. The Director now owns 162,193 shares after completing the transaction at $41.58 per share. On Jul 02 ’24, another insider, Howe Jolanda, who serves as the SVP, GLOBAL CONTROLLER of the company, sold 375 shares for $34.00 each. As a result, the insider received 12,750 and left with 2,426 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MIRM now has a Market Capitalization of 1859626624 and an Enterprise Value of 1897813760. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.03 while its Price-to-Book (P/B) ratio in mrq is 8.10. Its current Enterprise Value per Revenue stands at 7.178 whereas that against EBITDA is -21.382.

Stock Price History:

Over the past 52 weeks, MIRM has reached a high of $45.23, while it has fallen to a 52-week low of $23.14. The 50-Day Moving Average of the stock is -4.31%, while the 200-Day Moving Average is calculated to be 25.22%.

Shares Statistics:

Over the past 3-months, MIRM traded about 605.43K shares per day on average, while over the past 10 days, MIRM traded about 516480 shares per day. A total of 46.72M shares are outstanding, with a floating share count of 37.94M. Insiders hold about 20.47% of the company’s shares, while institutions hold 95.92% stake in the company. Shares short for MIRM as of 1724976000 were 7122710 with a Short Ratio of 11.76, compared to 1722384000 on 7289291. Therefore, it implies a Short% of Shares Outstanding of 7122710 and a Short% of Float of 17.349999999999998.

Most Popular